Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis

NCT00275613 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00275613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00275613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2005
Completion date
March 31, 2009
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glomerulonephritis, membranoproliferative